Infectious Diseases

INDIANAPOLIS, June 15, 2026 Elanco Animal Health Incorporated has announced that the U.S. Department of Agriculture (USDA) has approved...

SALT LAKE CITY, Utah, June 8, 2026 Seek Labs announced a major milestone in antiviral research with the completion...

TEL AVIV, Israel and RALEIGH, N.C., June 2, 2026 RedHill Biopharma has announced efforts to advance the clinical development...

GAITHERSBURG, Md. | May 28, 2026 Emergent BioSolutions announced it has received a $64.5 million contract modification from the...

SUZHOU, China, May 26, 2026 WuXi Vaccines, a wholly owned subsidiary of WuXi Biologics specializing in vaccine Contract Development...

COPENHAGEN, Denmark, April 16, 2026 Bavarian Nordic A/S has announced that Swissmedic, the Swiss Agency for Therapeutic Products, has...

CAMBRIDGE, Mass., April 9, 2026 Vedanta Biosciences, a late clinical-stage biopharmaceutical company, has announced new scientific presentations showcasing its...

SHELTON, Connecticut, United States, April 7, 2026 NanoViricides, Inc., a clinical-stage biopharmaceutical company, announced that it has filed an...

OSAKA, Japan, April 8, 2026 Shionogi & Co., Ltd. presented new real-world clinical data for Fetroja®/Fetcroja® (cefiderocol) at ESCMID...

Shelton, Connecticut — February 10, 2026: NanoViricides, Inc., a clinical-stage antiviral nanomedicine company, announced the filing of an Orphan...